The BRAF Inhibitors market is expected to grow significantly in the coming years. This is due to the increasing number of patients being diagnosed with cancer, rise in biomarker testing rates, the ...

Combining surgery with chemotherapy significantly improves survival in GIST patients with liver metastases compared to chemotherapy alone. Median CSS and OS for combined treatment exceed 120 months, ...

This new study is expected to initiate in early 2026. CFT1946: CFT1946 is an oral degrader targeting BRAF V600 mutations for the potential treatment of solid tumors including colorectal cancer (CRC), ...

These therapies focus on specific genetic mutations or molecular drivers, such as EGFR, ALK, ROS1, BRAF, and MET, which are commonly implicated in NSCLC. Drugs targeting these mutations ...

But I don't feel like my patients colorectal cancer know if they have like a KRAS mutation or not or a BRAF mutation or not. So there is a huge gap here. And of course, the only way to fill this ...

Michael B. Jordan found himself mentioned on another Netflix real estate show — but this time because of his past situationship with Selling the City‘s Gisselle Meneses Nunez. During the first ...

Avutometinib is an oral RAF/MEK clamp which inhibits MEK1/2 kinase activities and induces inactive complexes of MEK with ARAF, BRAF, and CRAF. In turn, this creates a more durable anti-tumor response.